The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to Series A Loan Funding Agreement

23 Jul 2019 10:14

RNS Number : 4241G
Oilex Ltd
23 July 2019
 

ASX Announcement

 

23 July 2019

 

ASX: OEX

AIM: OEX

 

Amendment to Series A Loan Funding Agreement

 

Oilex Ltd (the Company) is pleased to advise that it has entered into an amendment agreement to vary the terms of its loan funding facility of A$330,000 (Amendment) entered into on 26 July 2018 (Series A Loan).

 

Pursuant to the Amendment, the loan repayment date has been extended from 26 July 2019 to 1 October 2019. In addition, the Company will issue 124,060,150 new options to the lenders at an exercise price of $0.00266. All other terms remain the same as the Series A Loan and are extended to 1 October 2019.

 

Summary of Key Terms after the Amendment

 

Term: 1 October 2019

Interest Rate: 5%

Repayments 100% payable at maturity

Options Issued: 124,060,150 options over ordinary shares

Option Exercise Price: A$0.00266 per option

Option Expiry Date: On 31 December 2019

Security: Unsecured

Key Undertakings: Not to dispose of assets having an aggregate value more than A$1 million

Not to incur any financial indebtedness more than A$50,000

Not to incur any aggregate payment or outgoing exceeding A$1 million (except for wages)

 

Customary additional provisions regarding events of default, undertakings, covenants and representations and warranties remain unchanged.

 

The options, which if exercised in their entirety, will result in a cash inflow to the Company of A$330,000. The proceeds from the conversion of options will be applied to the outstanding Series A Loan balance, which is fully drawn down.

 

The issue of the options is subject to shareholder approval under ASX Listing Rule 7.1 on or before 30 September 2019. Failure to secure shareholder approval will require immediate repayment of the loan principal and accrued interest. The Company is currently preparing the necessary notice of general meeting, which will be sent to shareholders shortly.

 

Related Party Transaction

 

Republic Investment Management Pte Ltd (Republic) makes up $300,000 of the Series A Loan balance of $330,000. Republic has a shareholding in the Company of 10.53% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, the entering into the Amendment with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the Amendment with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

For and on behalf of Oilex Ltd

 

Mark Bolton

Chief Financial Officer Company Secretary

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: mweir@citadelmagnus.com

Tel: +618 6160 4900

Australia

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLIFIADAIVFIA
Date   Source Headline
15th Aug 20187:00 amRNSNotice of General Meeting
13th Aug 20187:30 amRNSRestoration - Oilex Limited
13th Aug 20187:00 amRNSGSPC Event of Default Update & Trading Restoration
10th Aug 201812:35 pmRNSSuspension - Oilex Ltd
10th Aug 20187:00 amRNSTrading Halt
6th Aug 20187:05 amRNSExpiry of Unlisted Options
31st Jul 20187:00 amRNSJune 2018 Quarterly Report
30th Jul 20187:00 amRNSEvent of Default Notice Update
30th Jul 20187:00 amRNSTranche 2 Update
26th Jul 20187:00 amRNSLoan Funding & Cash Call Receipt
29th May 20187:00 amRNSIssue of Event of Default Notice - Cambay PSC
17th May 20187:00 amRNSNotice Change of Interests of Substantial Holder
15th May 20187:00 amRNSAppendix 3Y P Haywood
15th May 20187:00 amRNSAppendix 3Y B Lingo
15th May 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
30th Apr 201810:19 amRNSMarch 2018 Quarterly Report
30th Apr 201810:11 amRNSCapital Raising and T2 Variation
4th Apr 20187:00 amRNSMoPNG Approves Application for PSC Extensions
29th Mar 20187:00 amRNSAmendment to T2 Capital Raising Conditions
15th Mar 20187:00 amRNSManaging Director Contract Extension
14th Mar 20187:00 amRNSResults of 14 March 2018 General Meeting
1st Mar 20187:00 amRNSAppendix 3Y B Lingo
1st Mar 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
1st Mar 20187:00 amRNSAppendix 3Y P Haywood
26th Feb 20187:00 amRNSInvestor Presentation February 2018
22nd Feb 20187:47 amRNSInterim Report 31 December 2017
12th Feb 20187:00 amRNSNotice of General Meeting
1st Feb 20187:00 amRNSNotice of Initial Substantial Holder
29th Jan 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
29th Jan 20187:00 amRNSQuarterly Report 31 December 2017
22nd Dec 20177:00 amRNSExpiry of Unlisted Options
12th Dec 20178:29 amRNSAppendix 3B Issue of Shares and Section 708 Notice
12th Dec 20177:00 amRNSPlacement to New Cornerstone Shareholder
29th Nov 20177:00 amRNSAppendix 3Z M Cozijn
29th Nov 20177:00 amRNSChairman's Address to Shareholders
29th Nov 20177:00 amRNSResults of Annual General Meeting 29 November 2017
23rd Nov 20177:00 amRNSExpiry of Unlisted Options
13th Nov 201712:43 pmRNSInvestor Presentation November 2017
13th Nov 20177:00 amRNSExpiry of Unlisted Options
30th Oct 20177:00 amRNS2017 AGM Notice of Meeting
30th Oct 20177:00 amRNSBoard Changes
30th Oct 20177:00 amRNS2017 Annual Report to Shareholders
26th Oct 20179:50 amRNSQuarterly Report 30 September 2017
13th Sep 20177:00 amRNSCorporate Governance Statement
13th Sep 20177:00 amRNSGood Oil Investor Presentation September 2017
12th Sep 20179:40 amRNSFinancial Report for Year Ended 30 June 2017
12th Sep 20179:31 amRNSAppendix 4G
12th Sep 20179:29 amRNSUpdated Constitution
4th Sep 20178:07 amRNSAppendix 3B Issue of Shares and Section 708 Notice
29th Aug 20177:00 amRNSOilex Investor Presentation August 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.